NCT04535154 (PROLUN) is a clinical trial of No interventions in Covid19, sponsored by University Hospital, Akershus.

Who is sponsoring NCT04535154?

NCT04535154 is sponsored by University Hospital, Akershus.

What drugs are being tested in NCT04535154?

Interventions in NCT04535154: No interventions.

What condition does NCT04535154 study?

NCT04535154 studies Covid19, Lung Function Decreased.

Is NCT04535154 still recruiting?

NCT04535154 is currently status unknown. Last updated 1 September 2020.

Last reviewed 2020-09-01 · How we verify

NCT04535154: PROLUN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19

Status unknown Last updated 1 September 2020

What this trial tests

trial testing No interventions in Covid19 in 264 participants. Status unknown.

Timeline

31 March 2020

Primary endpoint
1 June 2021

1 June 2022

Quick facts

Lead sponsor	University Hospital, Akershus
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	264
Start date	31 March 2020
Primary completion	1 June 2021
Estimated completion	1 June 2022
Sites	1 location across Norway

Drugs / interventions tested

No interventions — full drug profile →

Conditions studied

Covid19 — all drugs for Covid19 →
Lung Function Decreased — all drugs for Lung Function Decreased →

Sponsor

University Hospital, Akershus

Who can join

18 and older, any sex, with Covid19 or Lung Function Decreased. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A multicenter prospective cohort study performed at 6 major teaching hospitals in Southern Norway to study patient reported outcomes, lung function and pulmonary CT in patients at 3 and 12 months after hospitalization for coronavirus disease 2019 (COVID-19).

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19.
Lerum TV, Aaløkken TM, Brønstad E, Aarli B, et al · · 2021 · cited 246× · PMID 33303540 · DOI 10.1183/13993003.03448-2020
Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation.
Skjørten I, Ankerstjerne OAW, Trebinjac D, Brønstad E, et al · · 2021 · cited 135× · PMID 34210791 · DOI 10.1183/13993003.00996-2021
Prevalence and Risk Factors for Post-Traumatic Stress in Hospitalized and Non-Hospitalized COVID-19 Patients.
Einvik G, Dammen T, Ghanima W, Heir T, et al · · 2021 · cited 52× · PMID 33672759 · DOI 10.3390/ijerph18042079
Cardiac Dysfunction and Arrhythmias 3 Months After Hospitalization for COVID-19.
Ingul CB, Grimsmo J, Mecinaj A, Trebinjac D, et al · · 2022 · cited 51× · PMID 35048715 · DOI 10.1161/jaha.121.023473
Changes in cardiopulmonary exercise capacity and limitations 3-12 months after COVID-19.
Ingul CB, Edvardsen A, Follestad T, Trebinjac D, et al · · 2023 · cited 24× · PMID 36137587 · DOI 10.1183/13993003.00745-2022
Changes in cardiac structure and function from 3 to 12 months after hospitalization for COVID-19.
Øvrebotten T, Myhre P, Grimsmo J, Mecinaj A, et al · · 2022 · cited 14× · PMID 35920837 · DOI 10.1002/clc.23891
The course and determinants of post-traumatic stress over 12 months after hospitalization for COVID-19.
Stavem K, Heir T, Dammen T, Brønstad E, et al · · 2022 · cited 3× · PMID 35911221 · DOI 10.3389/fpsyt.2022.931349
Minor Myocardial Scars in Association with Cardiopulmonary Function after COVID-19.
Øvrebotten T, Heck S, Skjørten I, Einvik G, et al · · 2023 · cited 1× · PMID 37231850 · DOI 10.1159/000530942

Verify or expand the search:

Other trials of No interventions

Trials testing the same drug.

NCT07497815 — Artificial Intelligence-assisted Diagnosis in Ophthalmology · not yet recruiting
NCT07509632 — Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning · active not recruiting
NCT07307040 — Precision Diabetes Management: Integrated East-West Approach · not yet recruiting
NCT07276945 — Individualized Early Diagnosis and Treatment System of Gestational Diabetes Mellitus (GDM) Based on New Continuous Gluco · not yet recruiting
NCT06999681 — Postoperative Arrhythmia and Preoperative Cardiac Function · not yet recruiting

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other University Hospital, Akershus trials

Trials by the same sponsor.

NCT06865027 — The Effect of Arterial Carbon Dioxide Levels on Cerebral Blood Flow and Cerebral Autoregulation in the Steep Trendelenbu · NA · enrolling by invitation
NCT06721754 — Diabetes Related Foot Ulcers with Negative Pressure Wound Therapy · NA · recruiting
NCT06731985 — The Follow-up After Shorter Tapes Study. Effectiveness and Safety of Shorter Trans-obturator Tapes. · recruiting
NCT06576752 — Management of Patients with Heart Failure At Home After Hospital Discharge · NA · recruiting
NCT06032715 — Brief Intervention for Sleep Medication Misuse Among Elderly · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04535154 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Akershus
Last refreshed: 1 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04535154.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing